July 15, 2026 -
August 5, 2026
This three-part webinar series provides a comprehensive overview of the federal and state labeling requirements applicable to consumer products. Designed for regulatory affairs, product development, legal, and marketing professionals, this series will cover the full spectrum of compliance obligations — from federal agency mandates to state-level restrictions and marketing claims standards.
Session one will focus on requirements administered by the Consumer Product Safety Commission (CPSC), including product safety evaluation, toxicity categories, results of assessments, and compiling the label for compliance with the Federal Hazardous Substances Act (FHSA) and other considerations under CPSC’s jurisdiction.
Session two will focus on the substantiation of marketing claims, various obligations under the Federal Trade Commission (FTC), including the Fair Packaging and Labeling Act (FPLA), and the boundaries of pesticidal claims under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA).
The series will conclude with a session on other federal and state-level requirements, covering topics such as volatile organic compound (VOC) limits, Prop 65, phosphate restrictions, ingredient communication, and other mandates that impact consumer product labeling.
Week 1: July 15, 2026
1:00 - 2:30 pm
Consumer Product Safety Commission
Week 2: July 29, 2026
1:00 - 2:30 pm
Federal Trade Commission and Marketing Claims
Week 3: August 5, 2026
1:00 -2:30 pm
Other Federal and State-Level Requirements
View
August 12, 2026
From Bench to Building: Product Development Constraints When Translating Antimicrobial Test Methods to Real-World Use
Kayla Crouch, Microbiologist, Solenis, will explore the challenges of translating standardized antimicrobial test methods into real-life product performance for household and industry applications. Pulling from product development experience, the presentation will outline how performance criteria, test conditions, and method design can constrain formulation decisions and influence assumed product efficacy.
Discussing topics such as appropriate screening assays, simplified methods, complexity of the field, soil load limitations, and more, Kayla hopes to encourage thought that sees standardized testing as critical while being able to address the gaps in efforts to bridge them.
Takeaways:
- How to critically review antimicrobial testing methods during product development.
- How to align R&D, marketing, and regulatory expectations.
- Strategic ways to understand method data in the context of real-world applications.
View
